Heron Therapeutics, Inc.HRTXNASDAQ
Loading
Debt to Assets Over TimeFair Value
Percentile Rank71
3Y CAGR-4.3%
5Y CAGR+51.2%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-4.3%/yr
vs +182.2%/yr prior
5Y CAGR
+51.2%/yr
Recent deceleration
Acceleration
-186.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
7.9x
Strong expansion
Streak
2 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.55 | -27.9% |
| 2024 | 0.76 | -5.6% |
| 2023 | 0.81 | +28.6% |
| 2022 | 0.63 | +20.3% |
| 2021 | 0.52 | +649.5% |
| 2020 | 0.07 | +80.3% |
| 2019 | 0.04 | +290.0% |
| 2018 | 0.01 | -91.9% |
| 2017 | 0.12 | -84.4% |
| 2016 | 0.78 | - |